CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans.
Saved in:
| Title: | CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. |
|---|---|
| Authors: | Beatty GL; Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, 421 Curie Boulevard, Philadelphia, PA 19104, USA., Chiorean EG, Fishman MP, Saboury B, Teitelbaum UR, Sun W, Huhn RD, Song W, Li D, Sharp LL, Torigian DA, O'Dwyer PJ, Vonderheide RH |
| Source: | Science (New York, N.Y.) [Science] 2011 Mar 25; Vol. 331 (6024), pp. 1612-6. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
